Maibach, H.T.; Brownstein, M.J.; Hersch, S.M.; Anderson, K.E.; Itzkowitz, D.E.; Damiano, E.M.; Simon, N.G.
The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington’s Disease. J. Pers. Med. 2022, 12, 1561.
https://doi.org/10.3390/jpm12101561
AMA Style
Maibach HT, Brownstein MJ, Hersch SM, Anderson KE, Itzkowitz DE, Damiano EM, Simon NG.
The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington’s Disease. Journal of Personalized Medicine. 2022; 12(10):1561.
https://doi.org/10.3390/jpm12101561
Chicago/Turabian Style
Maibach, Hilda T., Michael J. Brownstein, Steven M. Hersch, Karen E. Anderson, Debra E. Itzkowitz, Eve M. Damiano, and Neal G. Simon.
2022. "The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington’s Disease" Journal of Personalized Medicine 12, no. 10: 1561.
https://doi.org/10.3390/jpm12101561
APA Style
Maibach, H. T., Brownstein, M. J., Hersch, S. M., Anderson, K. E., Itzkowitz, D. E., Damiano, E. M., & Simon, N. G.
(2022). The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington’s Disease. Journal of Personalized Medicine, 12(10), 1561.
https://doi.org/10.3390/jpm12101561